Among the 25 patients with PCa, the PSA level was >3 ng/mL in 13 (52%), and these patients would most likely not have undergone biopsy on the basis of the traditional PSA-based screening schedules [57]. This evidence concerns the gene KLK3 and posterior cortical atrophy.